NCT06872138Completed
S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis
Source: ClinicalTrials.gov · Last updated 21 May 2025
Brief summary (registry, in English)
This study aims to evaluate both serum and urine S100A8 as potential biomarkers for Lupus nephritis (LN)
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 70 (actual)
- First submitted
- 6 Mar 2025
- Start date
- 1 Nov 2024
- Primary completion date
- 30 Mar 2025
- Lead sponsor
- Theodor Bilharz Research Institute
- Diseases
- Lupus (SLE)
- NCT number
- NCT06872138
What you commit to
- Study type: Observational
- Participants enrolled: 70
- From 1 Nov 2024 to the primary completion date, 30 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Immunosuppressive drugs.
- Corticosteroid.
Other illness
- Autoimmune diseases.
- Sjogren's syndrome.
- Taking other biologic disease-modifying anti-rheumatic drugs.
Other
- Rheumatoid arthritis.
- Systemic sclerosis.
Who the study is looking for
- Age ≥ 18 years.
- Both sexes.
- Patients with Systemic lupus erythematosus (SLE)
- Patients with SLE and renal affection. SLE diagnosis is based on the 1997 American College of Rheumatology (ACR) criteria or the 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria.
- Renal involvement (lupus Nephritis) (LN) can be diagnosed by presence of proteinurea or elevated kidney function and can be confirmed by biopsy if present.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Theodor Bilharz Research Institute Coordinator of this site? Confirm its status | Giza | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.